TY - JOUR
T1 - Chemical constituents from fruits of Cnestis ferruginea Vahl ex. DC (Connaraceae) and evaluation of their anticholinesterase and antiradical activities
AU - Maleu, Thérèse Christelle
AU - Talla, Rostan Mangoua
AU - Kamdem, Michael Hermann Kengne
AU - Alfred Ngenge, Tamfu
AU - Kucukaydin, Selcuk
AU - Mmutlane, Edwin Mpho
AU - Ndinteh, Derek Tantoh
AU - Djama Mbazoa, Celine
AU - Wandji, Jean
N1 - Publisher Copyright:
© 2022 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - The phytochemical investigation of the DCM/MeOH (1:1) extract of the fruits of Cnestis ferruginea led to the isolation and characterization of one new quinic acid derivative, ferruginoic acid (1), together with six known compounds 2–7. Compounds 3–7 were reported for the first time from this species. The structures of compounds 1–7 were elucidated on the basis of 1 D and 2 D NMR spectroscopic data, mass spectrometry and by comparison of spectroscopic data with those from the literature. The anticholinesterase (AChE and BChE) activity and DPPH free radical scavenging assay of compounds 1, 3, 4 and 7 were evaluated. Ferruginoic acid (1) exhibited moderate anticholinesterase activity with IC50 value of 36.18 ± 1.78 µg/mL against AChE. Compounds 3, 4 and 7 showed high activity against free radical (DPPH•) scavenging assay (DPPH) with IC50 values 40.09 ± 0.96 µg/mL, 61.70 ± 0.78 µg/mL and 41.87 ± 0.62 µg/mL respectively. These results indicate that C. ferruginea and its constituents could be employed in the management of Alzheimer’s disease.
AB - The phytochemical investigation of the DCM/MeOH (1:1) extract of the fruits of Cnestis ferruginea led to the isolation and characterization of one new quinic acid derivative, ferruginoic acid (1), together with six known compounds 2–7. Compounds 3–7 were reported for the first time from this species. The structures of compounds 1–7 were elucidated on the basis of 1 D and 2 D NMR spectroscopic data, mass spectrometry and by comparison of spectroscopic data with those from the literature. The anticholinesterase (AChE and BChE) activity and DPPH free radical scavenging assay of compounds 1, 3, 4 and 7 were evaluated. Ferruginoic acid (1) exhibited moderate anticholinesterase activity with IC50 value of 36.18 ± 1.78 µg/mL against AChE. Compounds 3, 4 and 7 showed high activity against free radical (DPPH•) scavenging assay (DPPH) with IC50 values 40.09 ± 0.96 µg/mL, 61.70 ± 0.78 µg/mL and 41.87 ± 0.62 µg/mL respectively. These results indicate that C. ferruginea and its constituents could be employed in the management of Alzheimer’s disease.
KW - anticholinesterase activity
KW - Cnestis ferruginea
KW - Connaraceae
KW - DPPH scavenging
KW - Ferruginoic acid
UR - http://www.scopus.com/inward/record.url?scp=85126136517&partnerID=8YFLogxK
U2 - 10.1080/14786419.2022.2048299
DO - 10.1080/14786419.2022.2048299
M3 - Article
C2 - 35249440
AN - SCOPUS:85126136517
SN - 1478-6419
VL - 36
SP - 5950
EP - 5958
JO - Natural Product Research
JF - Natural Product Research
IS - 23
ER -